SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 702.90+3.1%10:42 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
DewDiligence_on_SI
To: DewDiligence_on_SI who wrote (2756)10/11/2019 2:30:55 PM
From: Miljenko Zuanic1 Recommendation  Read Replies (2) of 3557
 
Thanks.
KOD is interesting to follow, but KSI-301 may not be an ideal candidate as company presented in October ( ir.kodiak.com.
On slide 9, Abs in 301 is 68KD, so 5 mg (as Abs) is 70 mg of 301 in 0.1 mL. This is SYSTEMIC dose?????

Will listen presentation for more details.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News